Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Clinical practice. Preventing nephropathy induced by contrast medium.

Barrett BJ, Parfrey PS.

N Engl J Med. 2006 Jan 26;354(4):379-86. Review. No abstract available.

PMID:
16436769
2.

Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.

Calabrò P, Bianchi R, Caprile M, Sordelli C, Cappelli Bigazzi M, Palmieri R, Gigantino G, Limongelli G, Capozzi G, Cuomo S, Calabrò R.

Minerva Cardioangiol. 2010 Feb;58(1):35-40.

PMID:
20145594
3.

Contrast-induced kidney injury: focus on modifiable risk factors and prophylactic strategies.

Kagan A, Sheikh-Hamad D.

Clin Cardiol. 2010 Feb;33(2):62-6. doi: 10.1002/clc.20687. Review.

4.

The value of hydration and acetylcysteine in the prevention of contrast-induced nephropathy: a potentially catastrophic complication of the percutaneous coronary interventions.

Iyisoy A, Celik T, Yuksel UC, Bugan B, Isik E.

Int J Cardiol. 2009 May 29;134(3):431-3; author reply 434. doi: 10.1016/j.ijcard.2007.12.123. Epub 2008 May 23.

PMID:
18501445
5.

[The use of acetylcysteine for preventing contrast-induced nephropathy].

Schaad N, Barghouth G.

Rev Med Suisse. 2005 Jun 22;1(25):1693-6. Review. French. No abstract available.

PMID:
16117036
6.

Preventing nephropathy induced by contrast medium.

Tepel M.

N Engl J Med. 2006 Apr 27;354(17):1853-5; author reply 1853-5. No abstract available.

PMID:
16642596
7.

N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.

Stenstrom DA, Muldoon LL, Armijo-Medina H, Watnick S, Doolittle ND, Kaufman JA, Peterson DR, Bubalo J, Neuwelt EA.

J Vasc Interv Radiol. 2008 Mar;19(3):309-18. doi: 10.1016/j.jvir.2007.11.003. Review.

PMID:
18295688
8.

Preventing nephropathy induced by contrast medium.

Gross JL, Friedman R, Silveiro SP.

N Engl J Med. 2006 Apr 27;354(17):1853-5; author reply 1853-5. No abstract available.

9.

Selecting appropriate contrast media for preventing contrast-induced nephropathy.

[No authors listed]

Acta Radiol. 2008 Sep;49(7):787; author reply 788-9. No abstract available.

PMID:
19143064
10.

Contrast associated nephropathy in the elderly.

Carrillo-Alvira F, Rivera-Bermúdez CG, Jiménez-Velázquez IZ, Ramos-Romey C, González-Concepción JJ.

Bol Asoc Med P R. 2008 Jul-Sep;100(3):25-7.

PMID:
19227712
11.

N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials.

Zagler A, Azadpour M, Mercado C, Hennekens CH.

Am Heart J. 2006 Jan;151(1):140-5.

PMID:
16368307
12.

[Contrast-induced nephropathy in coronarography of patients with type 2 diabetes mellitus: risk factors, prognostic significance, prophylactic approaches].

Shamkhalova MSh, Zaĭtseva NV, Kurumova KO, Shestakova MV, Deev AD, Matskeplishvili ST, Tugeeva EF, Buziashvili IuI.

Ter Arkh. 2009;81(8):36-42. Russian.

PMID:
19799198
14.
15.
16.

Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics.

Coyle LC, Rodriguez A, Jeschke RE, Simon-Lee A, Abbott KC, Taylor AJ.

Am Heart J. 2006 May;151(5):1032.e9-12.

PMID:
16644332
17.

Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.

Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.

Am Heart J. 2003 Dec;146(6):E23.

PMID:
14661012
18.

N-acetylcysteine and contrast-induced nephropathy in primary angioplasty.

Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, De Metrio M, Galli S, Fabbiocchi F, Montorsi P, Veglia F, Bartorelli AL.

N Engl J Med. 2006 Jun 29;354(26):2773-82.

19.

Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.

Ferrario F, Barone MT, Landoni G, Genderini A, Heidemperger M, Trezzi M, Piccaluga E, Danna P, Scorza D.

Nephrol Dial Transplant. 2009 Oct;24(10):3103-7. doi: 10.1093/ndt/gfp306. Epub 2009 Jun 23.

PMID:
19549691
20.

The editor's roundtable: contrast agents and risk for contrast-induced nephropathy.

Friedewald VE, Goldfarb S, Laskey WK, Vetrovec GW, Roberts WC.

Am J Cardiol. 2011 Jun 15;107(12):1848-55. doi: 10.1016/j.amjcard.2010.10.001. No abstract available.

PMID:
21640219

Supplemental Content

Support Center